异动解读 | Rhythm Pharmaceuticals公布2024年Q4财报出色 盘中股价大涨5%

异动解读
27 Feb

Rhythm Pharmaceuticals Inc. (RYTM)今日盘中大涨5.01%,引起了市场的广泛关注。

公司发布的2024年第四季度财报显示营收实现4183万美元,超出市场预期的3848万美元。公司每股亏损0.72美元,则符合了市场对亏损0.73美元的预期。

从财报数据看,公司营收同比大增72.61%,业绩优于市场预期。因此公司财报出色是导致今日股价上涨的主要原因。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10